Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SEDLACEK H")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 28

  • Page / 2
Export

Selection :

  • and

EISENBAHNBRUECKENGERAETE IN STAHL, FRUEHER UND HEUTE = ELEMENT DE PONT FERROVIAIRE EN ACIER, HIER ET AUJOURD'HUISEDLACEK H.1976; BAUINGENIEUR; DTSCH.; DA. 1976; VOL. 51; NO 1; PP. 2-12; BIBL. 6REF.Article

Raumabschliessende Stahlkonstruktionen mit Stahlbändern = Eléments de traction feuilletés pour des toitures à longue portée = Sheeted tension members for large span roof structuresSEDLACEK, H.Bauingenieur. 1990, Vol 65, Num 10, pp 439-446, issn 0005-6650, 8 p.Article

Kinase inhibitors in cancer therapy : A look aheadSEDLACEK, H. H.Drugs (Basel). 2000, Vol 59, Num 3, pp 435-476, issn 0012-6667Article

Mechanisms of action of flavopiridolSEDLACEK, H. H.Critical reviews in oncology/hematology. 2001, Vol 38, Num 2, pp 139-170, issn 1040-8428Article

Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infectionDICKNEITE, G; KASPEREIT, F; HARALD SEDLACEK, H et al.Infection and immunity. 1984, Vol 44, Num 1, pp 168-174, issn 0019-9567Article

Recombinant monoclonal antibodies in tumor therapySEEMANN, G; BOSSLET, K; SEDLACEK, H.-H et al.Behring-Institute-Mitteilungen. 1990, Num 87, pp 33-47, issn 0301-0457, 15 p.Article

Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (±)-15-deoxyspergualinDICKNEITE, G; SCHORLEMMER, H. U; SEDLACEK, H. H et al.International journal of immunopharmacology. 1987, Vol 9, Num 5, pp 559-565, issn 0192-0561Article

Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes = Capacité pour la bestatine, dipeptide immunomodulateur, d'activer les phagocytes mononucléaires cytotoxiquesSCHORLEMMER, H. U; BOSSLET, K; SEDLACEK, H. H et al.Cancer research (Baltimore). 1983, Vol 43, Num 9, pp 4148-4153, issn 0008-5472Article

Aclarubicin: experimetal and clinical experienceRÖTHIG, H.-J; KRAEMER, H. P; SEDLACEK, H. H et al.Drugs under experimental and clinical research. 1985, Vol 11, Num 2, pp 123-125, issn 0378-6501Article

Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activationBOSSLET, K; CZECH, J; LORENZ, P et al.British journal of cancer. 1992, Vol 65, Num 2, pp 234-238, issn 0007-0920Article

Tumor therapy of neoplastic diseases with tumor cells and neuraminidase: experimental studies on chessboard vaccination in transplantation tumorsSEDLACEK, H. H; BENGELSDORFF, K. H; HAGMAYER, G et al.International journal of immunopharmacology. 1987, Vol 9, Num 7, pp 841-850, issn 0192-0561Article

Monocyte-related functions expressed in cell lines established from human pancreatic adenocarcinoma. I: Comparative analysis of endocytotic activity, lysosomal enzyme secretion, and superoxide anion productionKERN, H. F; BOSSLET, K; MOLENHAUER, J et al.Pancreas. 1987, Vol 2, Num 2, pp 212-221, issn 0885-3177Article

Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasiasBÄTGE, B; BOSSLET, K; SEDLACEK, H. H et al.Virchows Archiv. A, Pathological anatomy and histopathology. 1986, Vol 408, Num 4, pp 361-374, issn 0174-7398Article

Two-phase radioimmunotherapy using bispecific monoclonal antibodies (bs MAbs)BOSSLET, K; HERMENTIN, P; KUHLMANN, L et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 355-356, issn 0305-7372, 2 p.Article

Monocyte-related functions expressed in cell lines established from human pancreatic adenocarcinoma. II: Inhibition of stimulated activity by monoclonal antibodies reacting with surface antigens on tumor cellsKERN, H. F; BOSSLET, K; SEDLACEK, H. H et al.Pancreas. 1988, Vol 3, Num 1, pp 2-10, issn 0885-3177Article

Effect of the new immunostimulator HAB 439 on cell-mediated immunity against intracellular bacteriaDICKNEITE, G; SCHWAB, W; SCHORLEMMER, H. U et al.International journal of immunopharmacology. 1991, Vol 13, Num 5, pp 541-548, issn 0192-0561Article

Immunomodulation by the new synthetic thiazole derivative tiprotimod. II: Immunopharmacological activitySCHORLEMMER, H. U; DICKNEITE, G; BLUMBACH, J et al.Arzneimittel-Forschung. 1989, Vol 39, Num 9, pp 1085-1089, issn 0004-4172Article

The influence of aclacinomycin A on the immune response and on experimental immune disordersDICKNEITE, G; KURRLE, R; SEILER, F. R et al.International journal of immunopharmacology. 1984, Vol 6, Num 4, pp 307-313, issn 0192-0561Article

Monoclonal antibodies against epitopes on ganglioside GD2 and its lactonesBOSSLET, K; MENNEL, H. D; RODDEN, F et al.Cancer immunology and immunotherapy. 1989, Vol 29, Num 3, pp 171-178, issn 0340-7004, 8 p.Article

Prolongation of graft survival in allogeneic pancreas and liver transplantation by (-)15-deoxyspergualinTHIES, J. C; WALTER, P. K; ZIMMERMANN, F. A et al.European surgical research. 1987, Vol 19, Num 3, pp 129-134, issn 0014-312XArticle

A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I: Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differenciated adenocarcinomas of the pancreasBOSSLET, K; KERN, H. F; KANZY, E. J et al.Cancer immunology and immunotherapy. 1986, Vol 23, Num 3, pp 185-191, issn 0340-7004Article

Effect of adjuvant chemo-or immunotherapy on the prognosis of colorectal cancer operated for cureWUNDERLICH, M; SCHIESSEL, R; RAINER, H et al.British journal of surgery. 1985, Vol 72, pp 107-110, issn 0007-1323, supplArticle

Generation of bispecific monoclonal antibodies for two phase radioimmunotherapyBOSSLET, K; STEINSTRAESSER, A; HERMENTIN, P et al.British journal of cancer. 1991, Vol 63, Num 5, pp 681-686, issn 0007-0920, 6 p.Article

Islet transplantation with 15-deoxyspergualinWALTER, P; FEIFEL, G; JÄGER, S et al.Diabetologia (Berlin). 1987, Vol 30, Num 8, issn 0012-186X, 678Article

Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumor endothelial cellsMILLER, D. W; GRAULICH, W; KARGES, B et al.International journal of cancer. 1999, Vol 81, Num 4, pp 568-572, issn 0020-7136Article

  • Page / 2